TIBH

The industrial integrator TIBH is the result of the expertise of 3 organisations – TBI, TWB and CRITT-Bioindustries – in the field of industrial biotechnologies, and is part of the National Strategy for Accelerating Biotherapies and Bioproduction of Advanced Therapies of the France 2030 programme.
TIBH’s mission is to address the challenges of biomanufacturing in the healthcare sector, and in particular to propose innovative solutions, de-risk and accelerate the development of innovative therapies and bioprocesses.
TIBH is the only national healthcare integrator that aims to develop alternatives to conventional biomanufacturing by using microbial cell factories and designing appropriate bioprocesses at reduced cost.
TIBH plays a key role in securing and developing biomedical products in France and Europe. Drawing on its know-how, TIBH offers innovative scientific and technical strategies tailored to the needs of the industry. TIBH also stands out for its support in strengthening and validating proofs of concept established by academics and start-ups.

Thanks to its expertise, which is recognised by the industrial and academic ecosystems, TIBH has generated strong demand for collaboration: 20 opportunities, including 10 applications submitted, resulting in funding for 5 projects. The implementation of these projects is aimed, for example, at reducing the cost of producing monoclonal antibodies, optimising messenger RNA generation using new production frames, and developing on-line analysis and control systems.